Mr. Chair, I'll respond by saying that the assessment was that that provision did not need to be renewed. As I indicated, we were working with vaccine developers for their authorization that government has announced investments in and partnerships with a number of Canadian companies, as well as Novavax working with the NRC for production of vaccine in Canada.
On May 21st, 2021. See this statement in context.